SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-018181
Filing Date
2019-04-04
Accepted
2019-04-04 16:15:16
Documents
6
Period of Report
2019-05-14
Effectiveness Date
2019-04-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv517476-def14a.htm DEF 14A 743765
2 GRAPHIC lg_anipharma-black.jpg GRAPHIC 30343
3 GRAPHIC sg_arthur-przybyl.jpg GRAPHIC 35420
4 GRAPHIC sg_stephen-carey.jpg GRAPHIC 30530
5 GRAPHIC tv517476_proxycard-1.jpg GRAPHIC 295823
6 GRAPHIC tv517476_proxycard-2.jpg GRAPHIC 255575
  Complete submission text file 0001144204-19-018181.txt   1637684
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 19732443
SIC: 2834 Pharmaceutical Preparations